Abstract
The accelerated growth observed in some children with homocystinuria is attributed to the growth hormone-like and the insulin-like growth factor activities of homocysteine and homocysteic acid. In addition, homocysteine interferes with intramolecular cross-linkages of collagen, probably by reaction with lysyl aldehyde, causing abnormalities of skin, synovium, bone, and other connective tissues. The dislocation of ocular lenses in homocystinuria is caused by granular degeneration of zonular fibers. Deposition of fat within hepatocytes in homocystinuria is accompanied by ultrastructural abnormalities of mitochondria. Homocysteine thiolactone causes aggregation of low-density lipoprotein and converts thioretinaco to thioco, inhibiting oxidative metabolism, which may explain increased hepatic cholesterol and triglyceride synthesis. Atrophic, metaplastic, and dysplastic changes within gastric mucosa are attributed to the effects of homocysteine on sulfomucin, nucleo-protein, and keratin synthesis. Hyperhomocysteinemia produces fibrous arteriosclerotic plaques by a direct effect on the cells and tissues of arteries and arterioles in homocystinuria caused by the three principal types of enzyme deficiency. In addition, thrombosis of arteries and veins increases the risk of death from vascular disease by causing infarcts of brain, heart, kidneys, lung, and other organs. The discovery of the atherogenic effect of homocysteine on arteries in homocystinuria led to development of the homocysteine theory of arteriosclerosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
McKusick VA, Hall JG, Char F. The clinical and genetic haracteristics of homocystinuria. In: Carson NAJ, Raine DN (eds) Inherited Disorders of Sulphur Metabolism. Edinburgh: Churchill Livingstone, 1971, pp 179–203.
Schedwie H, Willich E, Grobe H, Schmidt H, Muller KM. Skeletal findings in homocystinuria: A collaborative study. Pediat Radiol 1:12–23, 1973.
Gaudier B, Remy J, Nuyts JP, Caron-Poitreau C, Bombart E, Foissac-Gegoux MC. Etude radiologique des signes osseux de l’homocystinurie. Arch Franc Fed 26:963–975, 1973.
Dehnel JM, Francis MJO. Somatomedin (sulphation factor-like activity of homocystine. Clin Sci 43:903–906, 1972.
Clopath P, Smith VC, McCully KS. Growth promotion by homocysteic acid. Science 192:372–374, 1976.
McCully KS. Growth disorders and homocysteine metabolism. Ann Clin Lab Sci 5:147–152, 1975.
McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 22:215–227, 1975.
Ricci R, McCully KS. Sulfation factor activity of homocysteic acid in cartilage cell cultures. Fed Proc 31:1460, 1971.
Schedwie HK, Lipinski C, Schmidt H. Elevated growth hormone levels in homocystinuria: Mechanism of tall stature? Clin Res 15:69A, 1977.
McCully KS. Importance of homocysteine-induced abnormalities of proteoglycan structure in arterio-scelrosis. Am J Pathol 59:181–193, 1970.
Uhlendorf BW, Mudd SH. Cystathionine synthase in tissue culture derived from skin: Enzymatic defect in homocystinuria. Science 160:1007–1009, 1968.
McCully KS. Macromolecular basis for homocysteine-induced changes in proteoglycan structure in growth and arteriosclerosis. Am J Pathol 66:83–95, 1972.
McCully KS, Vezeridis MP. Chemopreventive and antineoplastic activity of N-homocysteine thiolactonyl retinamide. Carcinogenesis 8:1559–1562, 1987.
McCully KS. Homocysteine metabolism in scurvy, growth and arteriosclerosis. Nature 231:391–392, 1971.
McCully KS. Chemical pathology of homocysteine. II Carcinogenesis and homocysteine thiolactone metabolism. Ann Clin Lab Sci 24:27–59, 1994.
Sundaresen PR. Vitamin A and the sulfate activating enzymes. Biochim Biophys Acta 113:95–109, 1966.
D’Abramo F, Lipmann F. The formation of adenosine 3’ phosphate 5’ phosphosulfate in extracts of chick embryo cartilage and its conversion into chondroitin sulfate. Biochim Biophys Acta 25:211–213, 1957.
Harris ED, Sjoerdsma A. Collagen profile in various clinical conditions. Lancet 2:707–711, 1966.
Kang AH, Trelstadt RL. A collagen defect in homocystinuria. J Clin Invest 52:2571–2578, 1973.
Jackson SH. The reaction of homocysteine with aldehyde: An explanation of the collagen defects in homocystinuria. Clin Chim Acta 45:215–217, 1973.
Mudd SH, Skovby F, Levy HL et al. The natural history of homocystinuria due to cystathionine beta synthase deficiency. Am J Hum Genet 37:1–31, 1985.
Henkind P, Ashton N. Ocular pathology in homocystinuria. Trans Ophthalmol Soc UK 85:21–38, 1985.
Ramsey MS, Yanoff M, Fine BS. The ocular histopathology of homocystinuria. Am J Ophthalmol 74: 377–385, 1972.
Spaeth GL, Barber GW. Homocystinuria: Its ocular manifestations. J Ped Ophthalmol 3:42–48, 1966.
Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic Basis of Inherited Disease, 6th ed. St Louis, MO; Mosby, 1989, pp 693–734.
Pyeritz RE. Homocystinuria. In: Beighton P (ed) McKusick’s Heritable Disorders of Connective Tissue, 5th ed. St Louis, MO: Mosby, 1993, pp 137–138.
Traboulsi EI, Silva JC, Geraghty MT, Maumenee IH, Valle D, Green WR. Ocular histopathologic characteristics of cobalamin C type vitamin B12 defect with methylmalonic aciduria and homocystinuria. Am J Ophthalmol 113:269–280, 1992.
Gibson JB, Carson NAJ, Neill DW. Pathological findings in homocystinuria. J Clin Pathol 17:427–437, 1964.
Carson NAH, Dent CE, Field GMB, Gaull GE. Homocystinuria: Clinical and pathological review of ten cases. J Pediat 66:565–583, 1965.
Schimke RN, McKusick VA, Huang T, Pollack AD. Homocystinuria: Studies of 20 families with 38 affected members. JAMA 193:711–719, 1965.
Carey MC, Donovan DE, Fitzgerald O, McAuley FD. Homocystinuria: I. A clinical and pathological study of nine subjects in six families. Am J Med 45:7–25, 1968.
McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111–128, 1969.
McCully KS. Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyl transferase deficiency: A key case revisited. Nutr Rev 50:7–12, 1992.
Kanwar YS, Manaligod JR, Wong PWK. Morphologie studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediat Res 10:598–609, 1976.
Gaull GE, Schaffner F. Electron microscopic changes in hepatocytes of patients with homocystinuria. Pediat Res 5:23–32, 1971.
Baumgartner ER, Wick H, Maurer R, Egli N, Steinmann B. Congenital defect in intracellular cobalamin metabolism resulting in homocystinuria and methylmalonic aciduria: I: Case report and histopathology. Helv Paediat Acta 34:465–482, 1979.
McCully KS, Vezeridis MP. Histopathological effects of homocysteine thiolactone on epithelial and stromal tissues. Exp Molec Pathol 51:159–170, 1989.
Gaggi R, Gianni AM. The role of homocysteine in the pathogenesis of arteriosclerosis. Proc First Cong Hung Pharmacol Soc 2:287–297, 1973.
McCully KS, Olszewski AJ, Vezeridis MP. Homocysteine and lipid metabolism in atherogenesis: Effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide. Atherosclerosis 83: 197–206, 1990.
Naruszewicz M, Mirkiewicz E, Olszewski AJ, McCully KS. Thiolation of low-density liporotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutr Metab Cardiovas Dis 4:70–77, 1994.
McCully KS. Chemical pathology of homocysteine: III. Cellular function and aging. Ann Clin Lab Sci 24:134–152, 1994.
Levy HL, Mudd SH, Schulman JD, Dreyfus PM, Abeles RH. A derangement in B12 metabolism associated with homocystinemia, cystathioninemia, hyper-methionemia and methylmalonic aciduria. Am J Med 48:390–397, 1970.
Baumgartner ER, Wick H, Linnell JC, Gaull GE, Bachmann C, Steinmann B. Congenital defect in intracellular cobalamin metabolism resulting in homocystinuria and methylmalonic aciduria: IL Biochemical investigations. Helv Paediat Acta 34:483–496, 1979.
Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Rad Biol Med 14:683–693, 1993.
DuVigneaud V, Patterson WI, Hunt M. Opening of the ring of the thiolactone of homocysteine. J Biol Chem 126:217–231, 1938.
McCully KS. Homocysteine thiolactone metabolism in malignant cells. Cancer Res 36:3198–3202, 1976.
Hughes PM, Zammit-Maempel I, Hughes M, Johnson RJ. Malignant fibrous histiocytoma: An unusual presentation. Brit J Radiol 64:847–849, 1991.
Collins JE, Brenton DP. Pancreatitis and homocystinuria. J Inker Metab Dis 13:232–233, 1990.
White HH, Rowland LP, Araki S, Thompson HL, Cowen D. Homocystinuria. Arch Neurol 13:455–470, 1965.
Chou S-M, Waisman HA. Spongy degeneration of the central nervous system: Case of homocystinuria. Arch Pathol 79:357–363, 1965.
Dunn HG, Perry RL, Dolman CL. Homocystinuria: A recently discovered cause of mental defect and cerebrovascular thrombosis. Neurol 16:407–420, 1966.
Hopkins I, Townley RRW, Shipman RT. Cerebral thrombosis in a patient with homocystinuria. J Pediat 75:1082–1083, 1969.
Vandresse JH, Saint Hubert ED, Evrard P. Homocystinuria and carotid arteriography. Neuroradiol 17:57–58, 1978.
Dayan AD, Ramsey RB. An inborn error of vitamin B12 metabolism associated with cellular deficiency of coenzyme forms of the vitamin: Pathological and neurochemical findings in one case. J Neurol Sci 23:117–128, 1974.
Case Records of the Massachusetts General Hospital. Case 19471: Marked cerebral symtoms following a limp of three months’ duration. N Engl J Med 209: 1063–1066, 1933.
Shih V, Efron ML. Pyridoxine-unresponsive homocystinuria: Final diagnosis of MGH Case 19471, 1933. N Engl J Med 183:1206–1208, 1970.
McCully KS. Homocysteine theory of arteriosclerosis: Development and current status. In: Gotto AMJr, Paoletti R (eds) Atherosclerosis Reviews, Vol. 11. New York, Raven Press, 1983, pp 157–246.
Rinehart JR, Greenberg LD. Arteriosclerotic lesions in pyridoxine deficient monkeys. Am J Pathol 25:481–491, 1949.
Hartroft WS, Ridout JH, Sellers EA, Best CH. Atheromatous changes in aorta, carotid and coronary arteries of choline deficient rats. Proc Soc Exp Biol Med 81:384–393, 1952.
McCully KS. Chemical pathology of homocysteine: I. Atherogenesis. Ann Clin Lab Sci 23:477–493, 1993.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
McCully, K.S. (1997). Pathology of Homocystinuria. In: Graham, I., Refsum, H., Rosenberg, I.H., Ueland, P.M., Shuman, J.M. (eds) Homocysteine Metabolism: From Basic Science to Clinical Medicine. Developments in Cardiovascular Medicine, vol 196. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5771-5_34
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5771-5_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7645-3
Online ISBN: 978-1-4615-5771-5
eBook Packages: Springer Book Archive